Literature DB >> 18306991

Endoscopic biliary imaging and clinicopathological features of cystic duct cancer.

Takashi Obana1, Naotaka Fujita, Yutaka Noda, Go Kobayashi, Kei Ito, Toshiki Sugawara, Jun Horaguchi, Osamu Takasawa, Takuro Endo, Kazunari Nakahara, Takashi Sawai, Miwa Uzuki, Mika Watanabe.   

Abstract

BACKGROUND: Cystic duct cancer fulfilling Farrar's criteria is relatively rare, but tumors whose origin is estimated to be in the cystic duct exist. The clinical features of such "broadly defined" cystic duct cancer have not been clarified.
METHODS: The endoscopic retrograde cholangiography (ERC) findings, intraductal ultrasonography (IDUS) findings, histological findings, and prognoses of 11 cases of cystic duct cancers resected at our institution (group C) were retrospectively analyzed. As a control group, 55 cases of middle or lower bile duct cancer (group B) were used (in 20 of the 55 cases of group B, tumors extended to the cystic duct intraluminally (group B-C (+)).
RESULTS: (1) ERC findings of group C as compared with those of group B-C (+) were as follows: (a) unilateral bile duct narrowing (spoon-like appearance): 55% versus 5% (P<0.01); (b) bilateral bile duct narrowing (apple-core-like appearance): 27% versus 95% (P<0.001). (2) IDUS was unable to visualize the cysticocholedochal junction (negative "confluence sign") more often in group C (67%) than in group B-C (+) (13%) (P<0.01). (3) Histologically, tumors extended to the gallbladder and the bile duct in 36% and 91% of the cases in group C, respectively. (4) The median survival time of the two groups was 21 and 28 months, respectively.
CONCLUSIONS: Cystic duct cancers frequently extended to the bile duct. The spoon-like appearance by ERC and the negative confluence sign by IDUS were characteristic findings.

Entities:  

Mesh:

Year:  2008        PMID: 18306991     DOI: 10.1007/s00535-007-2139-4

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  9 in total

1.  Primary carcinoma of the extrahepatic bile-ducts.

Authors:  D B BROWN; R STRANG; J GORDON; E B HENDRY
Journal:  Br J Surg       Date:  1961-07       Impact factor: 6.939

2.  Extrahepatic biliary-tract cancer.

Authors:  F GLENN; M R HILL
Journal:  Cancer       Date:  1955 Nov-Dec       Impact factor: 6.860

3.  Clinicopathological analysis of cystic duct carcinoma.

Authors:  Kun-Ming Chan; Ta-Sen Yeh; Jeng-Hwei Tseng; Nai-Jen Liu; Yi-Yin Jan; Miin-Fu Chen
Journal:  Hepatogastroenterology       Date:  2005 May-Jun

4.  Carcinoma of the cystic duct.

Authors:  D A T FARRAR
Journal:  Br J Surg       Date:  1951-09       Impact factor: 6.939

5.  Does aggressive surgical resection improve the outcome in advanced gallbladder carcinoma?

Authors:  M Miyazaki; H Ito; K Nakagawa; S Ambiru; H Shimizu; A Okuno; S Nozawa; Y Nukui; H Yoshitomi; S Furuya; K Kusashio; N Nakajima
Journal:  Hepatogastroenterology       Date:  1999 Jul-Aug

6.  Cystic duct carcinoma: a proposal for a new "working definition".

Authors:  Ilgin Ozden; Junichi Kamiya; Masato Nagino; Katsuhiko Uesaka; Koji Oda; Tsuyoshi Sano; Satoshi Kamiya; Yuji Nimura
Journal:  Langenbecks Arch Surg       Date:  2002-11-29       Impact factor: 3.445

Review 7.  Carcinoma of the cystic duct leading to obstructive jaundice. A case report and review of the literature.

Authors:  F Holzinger; M Schilling; K Z'graggen; S Stain; H U Baer
Journal:  Dig Surg       Date:  1998       Impact factor: 2.588

Review 8.  Primary carcinoma of the cystic duct.

Authors:  K Chijiiwa; M Torisu
Journal:  J Clin Gastroenterol       Date:  1993-06       Impact factor: 3.062

9.  Mucin-producing carcinoma of the cystic duct that caused obstructive jaundice.

Authors:  Akiyoshi Nemoto; Hiromichi Goshima; Shuuji Yoshimine; Takashi Higashiguchi; Keiko Takagi; Koji Fujii; Hiroya Kato
Journal:  Hepatogastroenterology       Date:  2003 Sep-Oct
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.